Prior to the use of the combined treatment of cytoreductive surgery (CRS) and perioperative chemotherapy (POC), peritoneal metastases were uniformly fatal. While the combined treatment of CRS and POC has been practiced for nearly 30 years, the benefits of the treatment are just emerging. This text is for surgical and medical oncologists, and describes the rationale, treatment, and results of treatment of peritoneal metastases, peritoneal mesothelioma, and sarcomatosis.
Internationally renowned peritoneal surface oncology teams have authored the chapters. The text is accompanied by surgical video presentations which includes on-camera commentary by the international experts offering his or her own approach to CRS and POC.
"This well-written book will definitely contribute to increasing the awareness of this highly aggressive treatment, and ultimately, optimize the outcomes."
Ms. Lene Hjerrild Iversen, DMSci, PhD
Professor Søren Laurberg, DMSci
Aarhus University Hospital
View the complete book review
- An overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy
- Colorectal cancer: prevention and treatment of peritoneal metastases
- Pseudomyxoma peritonei and peritoneal metastases from appendiceal malignancy
- Prevention and treatment of peritoneal metastases from gastric cancer
- Epithelial ovarian cancer with peritoneal metastases
- Diffuse malignant peritoneal mesothelioma
- Sarcomatosis and imatinib-resistant GISTosis: diagnosis and therapeutic options
- Management of unusual abdominal and pelvic neoplasms with peritoneal dissemination: case reports and literature review
- Pharmacology of perioperative cancer chemotherapy
- Patient- and treatment-related variables, adverse events and their statistical relationship for treatment of peritoneal metastases